THE ROLE OF CAMPYLOBACTER JEJUNI INFECTION IN THE DEVELOPMENT OF GUILLAIN-BARRÉ SYNDROME

1.Ang C.W., Jacobs B.C., Laman J.D.: The Guillain-Barre’ syndrome: a true case ofmolecular mimicry. Trends Immunol. 25, 6–66 (2004)Search in Google Scholar

2.Ashgar S.S., Oldfield N.J., Wooldridge K.G., Jones M.A., Irving G.J., Turner D.P., Ala’Aldeen D.A.: CapA, an autotransporter protein of Campylobacter jejuni mediates association with human epithelial cells and colonization of the chicken gut. J. Bacteriol. 189, 1856–1865 (2007)10.1128/JB.01427-06185576917172331Search in Google Scholar

3.Awad W.A., Hess C., Hess M.: Enteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickens. Toxins, 9(2017)10.3390/toxins9020060533143928208612Search in Google Scholar

4.Avrain L., Vernozy-Rozand C., Kempf I.: Evidence for natural horizontal transfer of tetO gene between Campylobacter jejunistrains in chickens. J. Appl. Microbiol. 97, 134–140 (2004)Search in Google Scholar

5.Backert S., Boehm M., Wessler S., Tegtmeyer N i wsp.: Transmigration route of Campylobacter jejuni across polarized intestinal epithelia cells: paracellular, transcellular or both? Cell Commun. Signal. 11, 72–87 (2013)Search in Google Scholar

6.Bilińka M., Koszewicz M.: Zespół Millera-Fishera z dominującymi zaburzeniami połykania i mowy. Adv. Clin. Exp. Med. 13, 515–519 (2004)Search in Google Scholar

7.Bolinger H., Kathariou S.: The Current state of macrolide resistance in Campylobacter spp.: Trends and impacts of resistance mechanisms. Appl. Environ. Microbiol. 83, e0046-17 (2017)Search in Google Scholar

8.Bronnec V., Turo H., Bouju A., Cruveiller S., Rodrigues R., Demnerova K., Tresse O., Haddad N., Zagorec M.: Adhesion, biofilm formation, and genomic features of Campylobacter jejuniBf, an atypical strain able to grow under aerobic conditions. Front. Microbbiol. 7, 1002 (2016)10.3389/fmicb.2016.01002492756327446042Search in Google Scholar

9.Bronowski C., James C.E., Winstanley C.: Role of environmental survival in transmission of Campylobacter jejuni. FEMS Microbiol. Lett. 356,8–19 (2014)Search in Google Scholar

10.Caldwell D.B., Wang Y., Lin J.: Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52, 3947–3954 (2008)10.1128/AAC.00450-08257310018779354Search in Google Scholar

11.Ó Cróinín T., Backert S.: Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Front. Cell. Infect. Microbiol. 2, 25 (2012)10.3389/fcimb.2012.00025341752722919617Search in Google Scholar

12.Chandrashekhar K., Kassem I. I., Rajashekara G.: Campylobacter jejuni transducer like proteins: Chemotaxis and beyond. Gut Microbes, 8, 323–334 (2017)10.1080/19490976.2017.1279380557041728080213Search in Google Scholar

13.Chopra I.: Mode of action of the tetracyclines and the nature of bacterial resistance to them, in The Tetracyclines (w) Handbook of Experimental. red.: Hlavka J.J., Boothe J.H., Springer, Berlin, Germany, 1985, s. 317392.10.1007/978-3-642-70304-1_6Search in Google Scholar

14.Coker O., Akitoye I., Raphael D., Thomas N., Bolaji A., Kehinde O., Obi L.C.: Human campylobacteriosis in developing countries. Emerg. Infect. Dis. 8, 237–243 (2002)Search in Google Scholar

15.Day C.J., Semchenko E.A., Korolik V.: Glycoconjugates play a key role in Campylobacter jejuni infection between host and pathogen. Front. Cell. Infect. 2, 1–8 (2012)Search in Google Scholar

16.Dimachkie M.M., Barohn R.J.: Guillain-Barré syndrome and variants. Neurol. Clin. 31, 491–510 (2013)Search in Google Scholar

17.Engberg J., Aarestrup F. M., Taylor D.E., Gerner-Smidt P., Nachamkin I.: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7, 24–34 (2001)Search in Google Scholar

18.Epps S.V.R., Harvey R.B., Hume M.E., Phillips T.D., Anderson R.C., Nisbet D.J.: Foodborne Campylobacter: Infections, Metabolism, Pathogenesis and Reservoirs. Int. J. Environ. Res. Public Health,10, 6292–6304 (2013)10.3390/ijerph10126292388111424287853Search in Google Scholar

19.Esson D., Grant A.J. i wsp.: Identyfication and initial characterisation of a protein involved in Campylobacter jejuni cell shape. Mirobial Pathogenesis, 104, 202–211 (2017)10.1016/j.micpath.2017.01.042533591828131954Search in Google Scholar

20.Faber E., Gripp E., Maurischat S, Kaspers B., Tedin K., Menz S., Zuraw A., Kershaw O., Yang I., Rautenschlein S., Josenhansa C.: Novel immunomodulatory Flagellin-Like Protein FlaC in Campy lobacter jejuni and other Campylobacterales. mSphere. 1, 1–24 (2015)Search in Google Scholar

21.Flanagan R.C., Neal-McKinney J.M., Dhillon A.S., Miller W.G., Konkel M.E.: Examination of Campylobacter jejuni putative adhesins leads to the identification of a new protein, designated FlpA, required for chicken colonization. Infect. Immun. 77, 2399–2407 (2009)10.1128/IAI.01266-08268732819349427Search in Google Scholar

22.Friis C., Wassenaar T.M., Javed M.A., Snipen L., Lagesen K., Hallin P.F., Newell D.G., Toszeghy M., Ridley A., Manning G., Ussery D.W.: Genomic characterization of Campylobacter jejunistrain M. PLoS One, 5, e12253 (2010)10.1371/journal.pone.0012253292872720865039Search in Google Scholar

23.Gibreel A. and Taylor D.E.: Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimic. Chemother. 58, 243–255 (2006)Search in Google Scholar

24.Guerry P., Monterino M.A. i wsp.: Campylobacter polysaccharide capsules: virulence and vaccines. Front. Cell. Infect. Microbiol. 2, 1–11 (2012)Search in Google Scholar

25.Han a Zifeng, Willer T., Li L., Pielsticker C., Rychlik I., Velge P., Kaspers B., Rautenschleina S.: Influence of the gut Microbiota composition on Campylobacter jejuni colonization in chickens. Infect. Immun. 85, 11e00380 (2017)10.1128/IAI.00380-17564901328808158Search in Google Scholar

26.Hermans D., van Deun K., Martel A., van Immerseel F., Messens W., Heyndrickx M., Haesebrouck F., Pasmans F.: Colonization factors of Campylobacter jejuni in the chicken gut. Vet. Res. 42, 82 (2011)10.1186/1297-9716-42-82315673321714866Search in Google Scholar

27.Hofreuter D.: Defining the metabolic requirements for the growth and colonization capacity of Campylobacter jejuni. Front. Cell. Infect Microbiol. 4, 137 (2014)10.3389/fcimb.2014.00137417842525325018Search in Google Scholar

28.Horrocks S.M., Anderson R.C., Nisbet D.J., Ricke S.C.: Incidence and ecology of Campylobacter jejuni and coli in animals. Anaerobe,15, 18–25 (2009)10.1016/j.anaerobe.2008.09.00118849005Search in Google Scholar

29.Ikeda N., Karlyshev A.V.: Putative mechanisms and biological role of coccoid form formation in Campylobacter jejuni. Eur. J. Microbiol. Immunol. 1, 41–49 (2012)Search in Google Scholar

30.Ilyas A.A., Mithen F.A., Chen Z.W., Cook S.D.: Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J. Neurol. Sci. 102, 67–75 (1992)Search in Google Scholar

31.Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.W., Cook S.D.: Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107, 111–121 (1992)Search in Google Scholar

32.Indikova I., Humphrey T.J., Hilbert F.: Survival with a helping hand: Campylobacter and microbiota. Front. Microbiol. 6, 1266 (2015)10.3389/fmicb.2015.01266463742026617600Search in Google Scholar

33.Iovine N. M.: Resistance mechanisms in Campylobacter jejuni. Virulence,4, 230–240 (2013)10.4161/viru.23753371198123406779Search in Google Scholar

34.Jannsen R., Krogfelt K.A, Cawthraw S.A., van pelt W., Wagenaar J.A., Owen R.J.: Host-pathogen interactions in Campylobacter infections: the host perspective. Clin.Microbiol. Rev. 21, 505–518 (2008)Search in Google Scholar

35.John D.A., Williams L.K., Kanamarlapudi V., Humphrey T.J., Wilkinson T.S.: The bacterial species. Campylobacter jejuniinduce diverse innate immune responses in human and avian intestinal epithelial cells. Front. Microbiol. 8, 1840 (2017)10.3389/fmicb.2017.01840562687729033908Search in Google Scholar

36.Johnson T.J., Shank J.M., Johnson J.G.: Current and potential treatments for reducing Campylobacter colonization in animal hosts and disease in humans. Front. Microbiol. 8, 1–14 (2017)Search in Google Scholar

37.Kaakoush N.O., Castańo-Rodríguez N., Mitchell H.M., Mana S.M.: Global epidemiology of Campylobacter infection. Clin. Microbiol. Rev. 28, 687–720 (2015)Search in Google Scholar

38.Kaakoush N.O., Mitchell H. M.: Campylobacter concisus – new player in intestinal disease. Front.Cell. Infect. Microiol. 2, 1–12 (2012)Search in Google Scholar

39.Kimoto. K., Koga M., Hirata K., Takahashi M., Li J., Gilbert M., Yuki N.: Relationship of bacterial strains to clinical syndromes of Campylobacter– associated neuropathies. Neurology. 67, 1837–1843 (2006)10.1212/01.wnl.0000244468.22377.6b17130419Search in Google Scholar

40.Kobierecka P.A., Jagusztyn-Krynicka E.K. i wsp.: In vitro characteristics of Lactobacillus spp. strains isolated from the chicken digestive tract and their role in the inhibition of Campylobactercolonization. Microbiol. Open. 6, 1–15 (2017)Search in Google Scholar

41.Koga M., Takahashi M., Masuda M., Hirata K., Yuki N.: Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology, 65, 1376–1381 (2005)10.1212/01.wnl.0000176914.70893.1416162859Search in Google Scholar

42.Koga M., Yuki N., Takahashi M., Saito K., Hirata K.: Close association of IgA anti-gangloside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher’s syndromes. J. Neuroimmunol. 81, 138–143 (1998)10.1016/S0165-5728(97)00168-9Search in Google Scholar

43.Kurtkiewicz A.: Kampylobakteriozy u ludzi i zwierząt. Życie Weterynaryjne, 83, 285–288 (2008)Search in Google Scholar

44.Mahajan S., Rodgeres F.G.: Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni. J. Clin. Microiol. 28, 1314–1320 (1990)Search in Google Scholar

45.Melo R.T., Mendonça E.P., Monteiro G.P., Siqueira M.C.: Intrinsic and extrinsic aspects on Campylobacter jejuni biofilms. Front. Microbiol. 8, 1–15 (2017)Search in Google Scholar

46.Miller C.E., Rock J.D., Ridley K.A., Williams P.H., Ketley J.M.: Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J. Bacteriol. 190, 1900–1911 (2008)10.1128/JB.01761-07225886418203832Search in Google Scholar

47.Mohan V.: The role of probiotics inthe inhibition of Campylobacter jejuni colonization and virulence attenuation. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1503–1513 (2015)Search in Google Scholar

48.Moran. A.P., Annuk H., Prendergast M.M.: Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J. Neuro-immunol. 165, 179–185 (2005)10.1016/j.jneuroim.2005.04.01315993494Search in Google Scholar

49.Nachamkin, I., Szymanski, M.C., Blaser, J.M.: Campylobacter. 3-cia ed.; ASM Press: Washington DC, USA (2008)10.1128/9781555815554Search in Google Scholar

50.Nothaft H., Szymański C.M. i wsp.: Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine. Scientific Reports, 6, 26511 (2016)10.1038/srep26511487952127221144Search in Google Scholar

51.Nyati K.K., Nyati R.: Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update. Biomed. Res. Int. 852195 (2013)10.1155/2013/852195375543024000328Search in Google Scholar

52.Nyati K.K., Prasad K.N.: Role of cytokines and Toll-Like receptors in the immunopathogenesis of Guillain-Barré syndrome. Mediators Inflamm. 758639, DOI:10.1155/2014/758639 (2014)10.1155/2014/758639418994725614713Search in Google Scholar

53.Palyada K.,Threadgill D. and Stintzi A.: Iron acquisition and regulationin Campylobacter jejuni. J. Bacteriol. 186, 4714–4729 (2004)Search in Google Scholar

54.Phongsisay V.: The immunobiology of Campylobacter jejuni: innate immunity and autoimmune diseases. Immunobiol. 221, 535–543 (2015)10.1016/j.imbio.2015.12.00526709064Search in Google Scholar

55.Prendergastm M., Moran A.P.: Lipooligosaccharidies in the development of Guillain-Barre’s syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral. Neuropathies J. Endotoxin Res. 6, 341–359 (2000)Search in Google Scholar

56.Ridley K.A., Rock J.D., Li Y., Ketley J.M.: Hem eutilizationin Campylobacter jejuni. J. Bacteriol. 188, 7862–7875 (2006)10.1128/JB.00994-06163629916980451Search in Google Scholar

57.Rokosz-Chudziak N., Rastawicki W.: Wybrane mechanizmy chorobotwórczości pałeczek Campylobacter jejuni. Med. Dośw. Mikrobiol. 66, 47–58 (2014)Search in Google Scholar

58.Sait-Cyr M.J., Guyard-Nicodeme M., Messaoudi S., Chemaly M., Cappelier J.M., Dousset X., Haddad N.: Recent advanced in screening of anti-Campylobacter activity in priobiotics for use in poultry. Front. Microiol. 7, 1–22 (2016)Search in Google Scholar

59.Saxena A.: Probiotics as a potential alternative for relieving peripheral neurophaties: a case for Guillain-Barre’s syndrome. Front. Microbiol. 6, 1497 (2015)10.3389/fmicb.2015.01497470375626779152Search in Google Scholar

60.Shu X.M., Cai F.C., Zhang X.P.: Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Muscle Nerve, 33, 225–231 (2006)10.1002/mus.2045716270308Search in Google Scholar

61.Silva J., Leite D., Fernandes M., Mena C., Gibbs P.A., Teixeira P.: Campylobacter spp. as a foodborne pathogen: a review. Front. Microbiol. 2, 200 (2011)10.3389/fmicb.2011.00200318064321991264Search in Google Scholar

62.Sofka D., Pfeifer A., Paulsen P., Hilbert F.: Changes with in the intestinal flora of broilers by colonisation with Campylobacter jejuni. Berl. Munch. Tierarztl.Wochenschr. 128, 104–110 (2015)Search in Google Scholar

63.Stahl M., Vallance B.A.: Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbe. 6, 143–148 (2015)10.1080/19490976.2015.1016691461536225831043Search in Google Scholar

64.Szymanski C.M. and Gaynor E.C.: How a sugary bug gets through the day. Recent developments in understanding fundamental processes impacting Campylobacter jejuni pathogenesis. Gut Microbe,3, 135–144 (2012)10.4161/gmic.19488337094622555465Search in Google Scholar

65.Wang Y., Sun S., Zhu J., Cui L., Zhang H.L.: Biomarkers of Guillain-Barre’s syndrome: Some recent progres, more still to be explored. Mediaors Inflamm. 5640098 (2015)10.1155/2015/564098458835126451079Search in Google Scholar

66.Watson A.E., Sandu P., Gundogdu O., Mills D.C., Inglis N.F., Manson E., Imrie L., Bajaj-Elliott M., Wren B.W., Smith David G.E., Dorrella N.: Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect. Immun. 80, 4089–4098 (2012)Search in Google Scholar

67.Wieczorek K., Osek J. Antimicrobial resistance mechanisms among Campylobacter. Biomed. Res. Int. 340605, DOI: 10.1155/ 2013/340605 (2013)10.1155/2013/340605370720623865047Search in Google Scholar

68.Xiang S.l., Zhong M., Cai F.C., Deng B., Zhang X.P.: The sialic acid residue i a crucial component of Campylobacter jejuni lipo-oligosaccharide ganglioside mimicry in the induction Guillain-Barre’s syndrome. J. Neuroimmunol. 174, 126–132 (2006)10.1016/j.jneuroim.2006.02.00916567003Search in Google Scholar

69.Xu F., Zeng X., Haigh R.D., Ketley J.M., Lin J.: Identification and characterization of a new ferric enterobactin receptor CfrB in Campylobacter. J. Bacteriol. 192, 4425–4435 (2010)10.1128/JB.00478-10293737920585060Search in Google Scholar

70.Yu R.K., Usuki S., Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain-Barre’ syndrome and related diseases. Infect. Immun. 74, 6517–6527 (2006)10.1128/IAI.00967-06169809216966405Search in Google Scholar

71.Yuki N. Guillain-Barre syndrome and anti-ganglioside antibodies a clinician scientist’s journey. Proc. Jpn. Acad., Ser. B. Phys Biol. Sci. 88, 299–326 (2012)10.2183/pjab.88.299342268522850724Search in Google Scholar

72.Yuki N.: Pathogenesis of Guillain-Barre and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Jpn. J. Infect. Dis. 2, 99–105 (1999)Search in Google Scholar

73.Yuki N, Hartung H.: Guillain-Barr’e Syndrome. New Engl. J. Med. 336, 294–304 (2012)Search in Google Scholar

74.Yuki N., Koga M.: Bacterial infections in Guillain-Barre and Fisher syndromes. Curr. Opin. Neurol. 19, 451–457 (1995)Search in Google Scholar

75.Yuki N., Odaka M.: Ganglioside mimicry as cause of Guillain-Barre’s syndrome. Curr. Opin. Neurol. 18, 557–561 (2005)Search in Google Scholar

76.Zang T., Dong J., Lu Q., Luo Q., Wen G., LiuG., Shao H.: Genotypic diversity, antymicrobial resistance and biofilm-forming abilities of Campylobacter isolated from chicken in Central China. Gut Pathogens, 9, 1–10 (2017)Search in Google Scholar

77.Zhang X.P., Gilbert M., Yuki N.,Cao F., Li J., Liu h., Lii Q., Meng F., Zhang J.: Association of anti GT1a antibodies with an outbreak of Guillain-Barre’s syndrome and analysis of gangliside mimicry in an associated Campylobacter jejuni strain. PLoS One,10, e0131730 (2015)10.1371/journal.pone.0131730451013026197476Search in Google Scholar